Award details

Developing new biomarkers of colorectal noeplasia: Quantification of aberrant CpG island methylation in human faecal DNA

ReferenceBBS/E/F/00051588
Principal Investigator / Supervisor Dr Ian Johnson
Co-Investigators /
Co-Supervisors
Institution Quadram Institute Bioscience
DepartmentQuadram Institute Bioscience Department
Funding typeResearch
Value (£) 4,887
StatusCompleted
TypeInstitute Project
Start date 01/10/2002
End date 30/11/2005
Duration38 months

Abstract

Colorectal cancer develops from adenomatous polyps that emerge gradually from aberrant fields of mucosal epithelial cells. Biomarkers are needed for research into the role of diet in the early stages of this common condition. We have developed 2 new methods to detect (Methylation-Specific PCR), and quantify (Methylation-specific restriction fragment length polymorphism) CpG island hyper-methylation in human faecal DNA, derived from colorectal epithelial cells. We now propose to use faecal samples to determine the occurrence of abnormal CpG island methylation, at 5 target genes, in both healthy volunteers and patients. We will also use a PCR-augmented genomic DNA subtraction technique to identify novel genes acquiring CpG island methylation early in the onset of neoplasia. Finally we will search for patterns of hyper-methylated genes that define early stages of the adenoma-carcinoma sequence, and design protocols for their use as faecal biomarkers in epidemiological and dietary studies.

Summary

unavailable
Committee Closed Committee - Agri-food (AF)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file